Key Technologies
- Migco's lead compound (MGX-008) is being developed to reduce the incidence and severity of migraine headaches
- The compound has been shown to be safe and well tolerated in a several randomized double placebo controlled clinical studies
- MGX-008 is produced in New Zealand using a US and worldwide patented process, and can be scaled up to very large quantities
